Edition:
United Kingdom

Julie Steenhuysen

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

26 Jun 2018

Modified polio vaccine extends lives in U.S. brain cancer study

CHICAGO Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumors who received standard therapies, U.S. researchers said on Tuesday. | Video

13 Jun 2018

Study confirms higher risk of dengue in kids who got Sanofi vaccine

CHICAGO, June 13 An analysis of data on Sanofi's dengue vaccine, which has been given to more than 800,000 school children in the Philippines, confirms it increases the risk of hospitalization and severe dengue in those who had never previously been infected with the mosquito-borne virus.

10 Jun 2018

Rise in U.S. suicides highlights need for new depression drugs

CHICAGO A spike in suicide rates in the United States has cast fresh light on the need for more effective treatments for major depression, with researchers saying it is a tricky development area that has largely been abandoned by big pharmaceutical companies.

09 Jun 2018

Rise in U.S. suicides highlights need for new depression drugs

CHICAGO A spike in suicide rates in the United States has cast fresh light on the need for more effective treatments for major depression, with researchers saying it is a tricky development area that has largely been abandoned by big pharmaceutical companies.

08 Jun 2018

Bourdain, Spade suicides highlight need for new depression drugs

CHICAGO, June 8 The suicides this week of Anthony Bourdain and Kate Spade have cast fresh light on the need for more effective treatments for major depression, an area that has been largely abandoned by big pharmaceutical companies.

04 Jun 2018

U.S. FDA wants to shorten new drug monopolies to cut costs

CHICAGO In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

03 Jun 2018

FDA wants to shorten new drug monopolies to cut costs

CHICAGO In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.

03 Jun 2018

Many women with early-stage breast cancer can skip chemotherapy: study

CHICAGO Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said on Sunday. | Video

02 Jun 2018

FDA chief outlines new ways to speed cancer drug approvals

CHICAGO The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up front to make sure applications companies submit are complete.

02 Jun 2018

Grail blood test shows promise in early detection of lung cancer

CHICAGO An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by tumours, according to preliminary results released on Saturday.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,626.33 + 25.88 +0.34%
DAX 12,661.54 + 100.52 +0.80%
CAC 40 5,422.54 + 13.11 +0.24%
TR Europe 178.23 -0.19 -0.11%
GBP/USD 1.3111 -0.01%
GBP/EUR 1.1245 +0.00%
EUR/USD 1.1655 -0.03%
Gold 1,225.70 +0.00 +0.00%
Oil 67.81 -0.27 -0.40%
Corn 347.00 +0.75 +0.22%